Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (1)
  • 2025 (2)
  • 2024 (1)
  • 2023 (3)
  • 2022 (5)
  • 2021 (1)
  • 2019 (1)

Subject

  • Drug Trafficking (118)
  • Arrests/Convictions - Major (83)
  • Synthetic drugs (74)
  • Seizures (Drugs/Property) (44)
  • Guns/Weapons (43)
  • Fake Pills (34)
  • Major Law Enforcement Operation (23)
  • Guilty Plea (21)
  • OCDETF/Task Force (14)
  • Overdose (13)
  • Take Back Day (13)
  • Outreach/Drug Prevention (12)
  • Pharmaceuticals/Pharmacists/Physicians (10)
  • Diversion Division (7)
  • Prevention/Education - DEA websites GSAD, JTT etc (6)
  • Extraditions (5)
  • Fentanyl Awareness (4)
  • Gangs (4)
  • Money Laundering (4)
  • Press Conferences (4)
  • Public and Media Affairs - also see Congressional Affairs (4)
  • Task Forces/Task Force Officers (4)
  • Counterfeit Pills (3)
  • International/Foreign Operations (3)
  • HIDTA (2)
  • One Pill Can Kill (2)
  • Asset Forfeiture (1)
  • Dark Web- Internet Trafficking (1)
  • El Paso Intelligence Center (1)
  • Narcoterrorism (1)
  • Other (1)
  • Recruitment/Office of Training/Graduations (1)
  • Red Ribbon (1)
  • Scam Calls (1)
  • Prescription Drugs (14)

Drug Name

  • Fentanyl (1)
  • Hydromorphone (1)
  • Morphine (1)
  • Oxycodone (1)

Field Division

  • Washington, DC (45)
  • St. Louis (39)
  • New York (35)
  • Seattle (25)
  • New England (24)
  • Sede (23)
  • Atlanta (19)
  • Miami (19)
  • Chicago (16)
  • Dallas (15)
  • New Jersey (15)
  • Houston (12)
  • San Francisco (12)
  • Louisville (10)
  • Los Angeles (9)
  • Omaha (9)
  • New Orleans (8)
  • Phoenix (6)
  • Rocky Mountain (6)
  • San Diego (6)
  • Detroit (3)
  • Philadelphia (1)
  • El Paso (14)
Clear All Results
14 Results - Showing 11 to 14
PRESS RELEASE

Las Cruces psychiatrist pleads guilty to unlawfully prescribing opioids

ALBUQUERQUE, N.M. – Mark Beale, 75, of Las Cruces, New Mexico, pleaded guilty on March 25 in federal court to unlawful dispensing and distributing of a schedule II controlled substance. Beale will remain on conditions of release pending sentencing. A federal grand jury indicted Beale on June 23, 2021. According...
PRESS RELEASE

Ready Pharmacy agrees to $400,000 settlement relating to Controlled Substances Act claims

ALBUQERQUE, N.M. – Fred J. Federici, U.S. Attorney for the District of New Mexico, has announced that Ready Pharmacy has agreed to a $400,000 settlement relating to civil claims brought by the Department of Justice on behalf of the U.S. Drug Enforcement Administration’s (DEA) El Paso Division Regulatory Diversion Group...
PRESS RELEASE

Man from Albuquerque pleads guilty to federal armed robbery of medical products and drug charges

ALBUQUERQUE, N.M. – Joseph Matney, 40, of Albuquerque, New Mexico, pleaded guilty in federal court on Feb. 4 to armed robbery of a pharmacy, theft of medical products and possession with intent to distribute Oxycodone and Alprazolam. According to his plea agreement, Matney entered and robbed an Albuquerque pharmacy on...
PRESS RELEASE

DEA and partners hold National Prescription Drug Take Back Day on April 27

EL PASO, Texas – With robust public participation over the course of 16 prior events, the National Prescription Drug Take Back Day Initiative continues to remove ever-higher amounts of opioids and other medicines from the nation’s homes, where they are vulnerable to misuse, theft or abuse by family members and...

Paginación

  • Primera página «
  • Anterior
  • Page 1
  • Current page 2
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster